P.8.6 Genotype/phenotype analysis in Chinese laminin-α2 deficient congenital muscular dystrophy patients

Hui Xiong,D.D. Tan,Suxia Wang,X.Z. Chang,Yakun Yuan,Xiru Wu

DOI: https://doi.org/10.1016/j.nmd.2013.06.507

IF: 3.538

2013-01-01

Neuromuscular Disorders

Abstract:Laminin-α2 (merosin) deficiency is an autosomal recessive disorder characterized by severe muscular dystrophy associated with typical abnormal white matter signal on brain MRI. It contributes to approximately half of the congenital muscular dystrophy (CMD) cases in the western world, but there are only a few clinical cases report in China. To determine the clinical and molecular genetic characteristics of merosin deficient congenital muscular dystrophy 1A (MDC1A), we studied 40 CMD patients with typical white matter abnormality and complete or partial deficiency of laminin-α2 diagnosed by immunohistochemistry staining. Genomic DNA was extracted using standard procedures from the peripheral blood leukocytes, and multiplex ligation-dependent probe amplification (MLPA) was applied to detect LAMA2 gene to identify genetic mutation. For those patients whose deletion/duplication mutation was not identified, LAMA2 gene mutation analysis were performed using PCR-DNA directly sequence. And then the relationships between genotype and phenotype were analyzed. We identified 71 mutations in LAMA2 gene of all 40 patients (88.75). Among these mutations, Most of them are compound heterozygous. We found 14 known and 31 previously undescribed mutations spanning all protein domains. Most of them were nonsense or splicing site or frame shift mutation causing laminin-α2 absence (73.4%). According to our research we further define the clinical manifestation and molecular genetic characteristics of a cohort of 40 Chinese pediatric patients with laminin-α2 deficient CMD, and our data suggest that the majority of laminin-α2 deficient patients in China showed LAMA2 gene mutations. Genetic characterization of affected families is valuable in prenatal diagnosis.